Press Releases
-
PDA Announces 2024 Drug Delivery Innovation Award Winners at Universe of Pre-Filled Syringes Conference
BETHESDA, Md., Oct. 22, 2024 /PRNewswire-PRWeb/ -- The Parenteral Drug Association (PDA) today announced the winners of the 2024 PDA Drug Delivery Innovation Awards during the opening plenary session of the 2024 PDA Universe of Pre-Filled Syringes and Injection Devices conference in Phoenix, Arizona. -
Ensuring Excellence: Bridging Science and Compliance at the PDA Pharmaceutical Microbiology Conference 2024
Washington, D.C. — The Parenteral Drug Association (PDA) 2024 PDA Microbiology Conference, October 7-9, is underway at the Grand Hyatt in Washington, D.C. -
The Annual PDA/FDA Joint Regulatory Conference Draws Record Audience
Today marks the start of the PDA/FDA Joint Regulatory Conference in Washington D.C. PDA is happy to announce that they have a new record in attendees for this prestigious event with over 900 people have attended. -
Just Released: Risk-Based Approach for Prevention and Management of Drug Shortages Technical Report
TR-68 provides a practical framework that companies can leverage, a triage model to assess drug shortage risks, and templates for developing a Drug Shortage Risk Register and Drug Shortage Prevention and Response Plan at a product level. -
Parenteral Drug Association and Euromed Communications Release Second Co-published book, Industrial Pharmaceutical Microbiology: Quality Control
The new title is co-edited by Edward C. Tidswell, Merck Exec. Dir. Of Sterile and Micro QA, and Radhakrishna Tirumalai, Sr. Principal Scientist at Merck Research Laboratories. -
ANSI/PDA Standard on Cryopreservation of Cells for Cell and Gene Therapies Receives Complete Recognition Status by U.S. FDA CBER
The 2021 standard is included in a cohort of standards relevant to regenerative medicine therapies recognized either completely or partially by the Center for Biologics in 2023. -
PDA Announces Collaboration with the U.S. FDA Concerning Services for Pharma Compounders
The collaboration will extend for four years and include expanded training opportunities and an interactive, in-person and virtual interest group for individuals in the outsourcing facility and compounding pharmacy. -
Parenteral Drug Association Announces the 2024 All-Volunteer Officers and Board of Directors
Anil Sawant becomes the Chair for 2024-2025; Melissa Seymour is Chair-Elect; Sue Schniepp becomes Im. Past Chair